SCOPUS 정보 검색 플랫폼

Volumn 76, Issue 1, 2009, Pages 1-3

Optimal use of FRAX®;Du bon usage du FRAX®

Author keywords

Densitometry; Fracture risk; FRAX ; Osteoporosis; Risk factors

Indexed keywords

EID: 58149305790 PISSN: 11698330 EISSN: None Source Type: Journal
DOI: 10.1016/j.rhum.2008.11.001 Document Type: Editorial

Times cited : (16)

References (10)

1
- 43049175471
- ® and the assessment of fracture probability in men and women from the UK
- ® and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19 (2008) 385-397
- (2008) Osteoporos Int , vol.19 , pp. 385-397
- Kanis, J.A.¹ Johnell, O.² Oden, A.³

2
- 0034883408
- An assessment tool for predicting fracture risk in postmenopausal women
- Black D.M., Steinbuch M., Palermo L., et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporose Int 12 (2001) 519-528
- (2001) Osteoporose Int , vol.12 , pp. 519-528
- Black, D.M.¹ Steinbuch, M.² Palermo, L.³

3
- 34347265759
- Assessment of nonvertebral fracture risk in postmenopausal women
- Roux C., Briot K., Horlait S., et al. Assessment of nonvertebral fracture risk in postmenopausal women. Ann Rheum Dis 66 (2007) 931-935
- (2007) Ann Rheum Dis , vol.66 , pp. 931-935
- Roux, C.¹ Briot, K.² Horlait, S.³

4
- 33646240321
- Ten-year absolute risk of osteoporotic fractures according to BMD T score at menopause: the Danish osteoporosis prevention study
- Abrahamsen B., Vestergaard P., Rud B., et al. Ten-year absolute risk of osteoporotic fractures according to BMD T score at menopause: the Danish osteoporosis prevention study. J Bone Miner Res 21 (2006) 796-800
- (2006) J Bone Miner Res , vol.21 , pp. 796-800
- Abrahamsen, B.¹ Vestergaard, P.² Rud, B.³

5
- 12344310388
- Intervention thresholds for osteoporosis in the UK
- Kanis J.A., Borgstrom F., Zethraeus N., et al. Intervention thresholds for osteoporosis in the UK. Bone 36 (2005) 22-32
- (2005) Bone , vol.36 , pp. 22-32
- Kanis, J.A.¹ Borgstrom, F.² Zethraeus, N.³

6
- 46649091797
- Cost-effective osteoporosis treatment thresholds: the United States perspective
- Tosteson A.N., Melton III L.J., Dawson-Hughes B., et al. Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19 (2008) 437-447
- (2008) Osteoporos Int , vol.19 , pp. 437-447
- Tosteson, A.N.¹ Melton III, L.J.² Dawson-Hughes, B.³

7
- 44649157879
- Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA
- Dawson-Hughes B., Tosteson A.N.A., Melton III L.J., et al. Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int 19 (2008) 449-458
- (2008) Osteoporos Int , vol.19 , pp. 449-458
- Dawson-Hughes, B.¹ Tosteson, A.N.A.² Melton III, L.J.³

8
- 51249116239
- ®-assessment and intervention thresholds for the UK
- ®-assessment and intervention thresholds for the UK. Osteoporos Int 19 (2008) 1395-1408
- (2008) Osteoporos Int , vol.19 , pp. 1395-1408
- Kanis, J.A.¹ McCloskey, E.V.² Johansson, H.³

9
- 0036820582
- Economic evaluation of interventions for osteoporosis
- Kanis J.A., and Jonsson B. Economic evaluation of interventions for osteoporosis. Osteoporos Int 13 (2002) 765-767
- (2002) Osteoporos Int , vol.13 , pp. 765-767
- Kanis, J.A.¹ Jonsson, B.²

10
- 58149280041
- National Institute for Health and Clinical Excellence. Final appraisal determination. Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women. London, NICE, 2007.
- National Institute for Health and Clinical Excellence. Final appraisal determination. Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women. London, NICE, 2007.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.